In Phase 3 of its clinical trial, Merck & Co's anti-COVID Molnupiravir may reach Indian markets soon. Here's what you need to know about its cost, side-effects and treatment.
Shiven a 23-year-old from Delhi was addicted to marijuana, alcohol, pornography, suicidal and self-harm tendencies. He tells us how he overcame it all.
The researchers at IIT Roorkie are conducting in-depth research on the drug piperazine, and have discovered its anti-viral properties could be used to tackle the disease.